Home > Insider Trading > Filing (0000904454-18-000702)

Filing Details

Accession Number:: 0000904454-18-000702
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-06 16:16:07
Reporting Period:: 2018-11-02

Accepted Time:: 2018-11-06 16:16:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1399529	Dicerna Pharmaceuticals Inc	DRNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1354718	K Brian Halak	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-11-02	189,359	$13.47	2,729,697	No	4	S	Indirect	By Domain Partners VIII, L.P.
Common Stock	Disposition	2018-11-02	1,412	$13.47	20,217	No	4	S	Indirect	By DP VIII Associates, L.P.
Common Stock	Disposition	2018-11-05	39,606	$12.98	2,690,091	No	4	S	Indirect	By Domain Partners VIII, L.P.
Common Stock	Disposition	2018-11-05	295	$12.98	19,922	No	4	S	Indirect	By DP VIII Associates, L.P.
Common Stock	Disposition	2018-11-06	102,067	$13.18	2,588,024	No	4	S	Indirect	By Domain Partners VIII, L.P.
Common Stock	Disposition	2018-11-06	761	$13.18	19,161	No	4	S	Indirect	By DP VIII Associates, L.P.
Common Stock	Disposition	2018-11-06	1,489	$14.16	2,586,535	No	4	S	Indirect	By Domain Partners VIII, L.P.
Common Stock	Disposition	2018-11-06	11	$14.16	19,150	No	4	S	Indirect	By DP VIII Associates, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Domain Partners VIII, L.P.
No	4	S	Indirect	By DP VIII Associates, L.P.
No	4	S	Indirect	By Domain Partners VIII, L.P.
No	4	S	Indirect	By DP VIII Associates, L.P.
No	4	S	Indirect	By Domain Partners VIII, L.P.
No	4	S	Indirect	By DP VIII Associates, L.P.
No	4	S	Indirect	By Domain Partners VIII, L.P.
No	4	S	Indirect	By DP VIII Associates, L.P.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.899. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.